Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6.03	12.58	10.81	28.95	7.11	35.41
Short-Term Investments	87.09	91.38	159.64	158.84	17.3	0
Cash & Cash Equivalents	93.12	103.95	170.45	187.78	24.4	35.41
Cash Growth	-27.22%	-39.01%	-9.23%	669.51%	-31.08%	159.72%
Other Current Assets	1.94	1.75	2.29	1.38	0.96	0.49
Total Current Assets	95.06	105.71	172.75	189.16	25.36	35.9
Property, Plant & Equipment	22.85	24.08	28.53	30.6	16.35	11.52
Long-Term Investments	21.46	26.41	23.94	85.35	0	0
Other Long-Term Assets	3.53	3.59	2.59	2.61	4.83	1.03
Total Long-Term Assets	47.84	54.08	55.06	118.56	21.18	12.55
Total Assets	142.89	159.78	227.81	307.72	46.54	48.45
Accounts Payable	2.22	2.99	3.59	3.57	1.6	2.1
Deferred Revenue	7.24	11.31	14.91	17.08	1.5	1.57
Current Debt	2.89	2.78	2.39	2.5	1.5	3.1
Other Current Liabilities	4.38	3.38	2.22	-1.82	6.66	1.89
Total Current Liabilities	16.72	20.46	23.12	21.33	11.26	8.66
Long-Term Debt	16.68	17.44	20.22	21.85	9.38	7.09
Other Long-Term Liabilities	5.33	9.15	12.96	14.42	25.55	1.04
Total Long-Term Liabilities	22.01	26.59	33.18	36.27	34.93	8.13
Total Liabilities	38.73	47.04	56.3	57.6	46.19	16.79
Total Debt	19.57	20.22	22.61	24.36	10.88	10.19
Debt Growth	-11.27%	-10.58%	-7.16%	123.91%	6.79%	25362.50%
Retained Earnings	-375.1	-364.29	-295.09	-206.99	-108.4	-47.67
Comprehensive Income	-0.04	0.04	-0.92	-0.32	0	0
Shareholders' Equity	104.16	112.74	171.51	250.12	-104.95	-45.85
Net Cash / Debt	73.55	83.74	147.84	163.43	13.53	25.23
Net Cash / Debt Growth	-30.54%	-43.36%	-9.54%	1108.26%	-46.38%	85.56%
Net Cash Per Share	1.93	2.21	3.96	4.92	6.43	12.65
Working Capital	78.33	85.25	149.63	167.83	14.1	27.24
Book Value Per Share	2.74	2.98	4.59	7.53	-49.92	-23.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).